134 related articles for article (PubMed ID: 20370685)
21. Structure and catalytic function of sphingosine kinases: analysis by site-directed mutagenesis and enzyme kinetics.
Baker DL; Pham TC; Sparks MA
Biochim Biophys Acta; 2013 Jan; 1831(1):139-46. PubMed ID: 23000541
[TBL] [Abstract][Full Text] [Related]
22. Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.
Tani K; Tabuchi K; Hara A
Neurotox Res; 2016 Jan; 29(1):35-46. PubMed ID: 26472207
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of selective inhibitors of sphingosine kinase 1.
Baek DJ; MacRitchie N; Pyne NJ; Pyne S; Bittman R
Chem Commun (Camb); 2013 Mar; 49(21):2136-8. PubMed ID: 23388656
[TBL] [Abstract][Full Text] [Related]
24. Targeting Sphingosine Kinases for the Treatment of Cancer.
Lewis CS; Voelkel-Johnson C; Smith CD
Adv Cancer Res; 2018; 140():295-325. PubMed ID: 30060814
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.
Pchejetski D; Böhler T; Stebbing J; Waxman J
Nat Rev Urol; 2011 Sep; 8(10):569-678. PubMed ID: 21912422
[TBL] [Abstract][Full Text] [Related]
27. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism.
Huwiler A; Döll F; Ren S; Klawitter S; Greening A; Römer I; Bubnova S; Reinsberg L; Pfeilschifter J
Biochim Biophys Acta; 2006 Mar; 1761(3):367-76. PubMed ID: 16571380
[TBL] [Abstract][Full Text] [Related]
28. Isoform-selective assays for sphingosine kinase activity.
Pitman MR; Pham DH; Pitson SM
Methods Mol Biol; 2012; 874():21-31. PubMed ID: 22528436
[TBL] [Abstract][Full Text] [Related]
29. Characterization of sphingosine kinase (SK) activity in Saccharomyces cerevisiae and isolation of SK-deficient mutants.
Lanterman MM; Saba JD
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):525-31. PubMed ID: 9601083
[TBL] [Abstract][Full Text] [Related]
30. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 Inhibitors.
Pyne NJ; Adams DR; Pyne S
Trends Pharmacol Sci; 2017 Jul; 38(7):581-591. PubMed ID: 28606480
[TBL] [Abstract][Full Text] [Related]
32. Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent.
Sun WY; Abeynaike LD; Escarbe S; Smith CD; Pitson SM; Hickey MJ; Bonder CS
Am J Pathol; 2012 Apr; 180(4):1740-50. PubMed ID: 22322303
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine kinase 2 deficiency increases proliferation and migration of renal mouse mesangial cells and fibroblasts.
Schwalm S; Timcheva TM; Filipenko I; Ebadi M; Hofmann LP; Zangemeister-Wittke U; Pfeilschifter J; Huwiler A
Biol Chem; 2015 Jun; 396(6-7):813-25. PubMed ID: 25781541
[TBL] [Abstract][Full Text] [Related]
35. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
[TBL] [Abstract][Full Text] [Related]
36. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
Uranbileg B; Ikeda H; Kurano M; Enooku K; Sato M; Saigusa D; Aoki J; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
PLoS One; 2016; 11(2):e0149462. PubMed ID: 26886371
[TBL] [Abstract][Full Text] [Related]
37. Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor.
Choi OH; Kim JH; Kinet JP
Nature; 1996 Apr; 380(6575):634-6. PubMed ID: 8602265
[TBL] [Abstract][Full Text] [Related]
38. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
Plano D; Amin S; Sharma AK
J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412
[TBL] [Abstract][Full Text] [Related]
39. Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes.
Pitson SM; D'andrea RJ; Vandeleur L; Moretti PA; Xia P; Gamble JR; Vadas MA; Wattenberg BW
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):429-41. PubMed ID: 10947957
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Biological Evaluation of BODIPY-PF-543.
Shrestha J; Hwang GT; Lee T; Kim SW; Oh YS; Kwon Y; Hong SW; Kim S; Seop Moon H; Baek DJ; Park EY
Molecules; 2019 Dec; 24(23):. PubMed ID: 31810327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
